Health Care & Life Sciences » Biotechnology | Carna Biosciences Inc.

Carna Biosciences Inc.

Carna Biosciences Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY95.52
Market Cap
JPY13.43 B
Shares Outstanding
9.62 M
Public Float
7.77 M

Profile

Address
BMA, 3/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.carnabio.com
Updated 09/14/2018
Carna Biosciences, Inc. engages in the drug discovery business. It operates through the following divisions: Drug Discovery Support; and Drug Discovery & Development. The Drug Discovery Support division provides drug discovery supporting products and services, such as kinase protein, profiling services, assay development, crystallography and cell based assay services.

Financials

View All
Created with Highcharts 5.0.14Carna Biosciences Inc.Net Income. Fiscal year is January-December. All values JPY Millions.2822828478474564562902907377372013201420152016201702004006008001000
Created with Highcharts 5.0.14Carna Biosciences Inc.Sales/Revenue. Fiscal year is January-December. All values JPY Millions.7717716126121 5691 569812812658658201320142015201620170500100015002000

Kohichiro Yoshino
President & Representative Director
Masaaki Sawa
Director, General Manager-Research & Development